429 related articles for article (PubMed ID: 19497250)
1. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.
Goldstein BI; Kemp DE; Soczynska JK; McIntyre RS
J Clin Psychiatry; 2009 Aug; 70(8):1078-90. PubMed ID: 19497250
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
4. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Guille C; Sachs GS; Ghaemi SN
J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
[TBL] [Abstract][Full Text] [Related]
5. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
Vitiello B; Riddle MA; Yenokyan G; Axelson DA; Wagner KD; Joshi P; Walkup JT; Luby J; Birmaher B; Ryan ND; Emslie G; Robb A; Tillman R
J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):867-78. PubMed ID: 22917200
[TBL] [Abstract][Full Text] [Related]
6. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
8. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
Samalin L; Llorca PM
Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
[TBL] [Abstract][Full Text] [Related]
9. Typical and atypical antipsychotics in bipolar depression.
Gao K; Gajwani P; Elhaj O; Calabrese JR
J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074
[TBL] [Abstract][Full Text] [Related]
10. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
11. Risperidone treatment of bipolar mania.
Nguyen LN; Guthrie SK
Ann Pharmacother; 2006 Apr; 40(4):674-82. PubMed ID: 16569811
[TBL] [Abstract][Full Text] [Related]
12. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder.
Popovic D; Reinares M; Amann B; Salamero M; Vieta E
Psychopharmacology (Berl); 2011 Feb; 213(4):657-67. PubMed ID: 21052983
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics: newer options for mania and maintenance therapy.
Vieta E; Goikolea JM
Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
15. Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review.
Rakofsky JJ; Dunlop BW
J Clin Psychiatry; 2011 Jan; 72(1):81-90. PubMed ID: 21208580
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
[TBL] [Abstract][Full Text] [Related]
17. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
[TBL] [Abstract][Full Text] [Related]
18. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
Liu HY; Potter MP; Woodworth KY; Yorks DM; Petty CR; Wozniak JR; Faraone SV; Biederman J
J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):749-62.e39. PubMed ID: 21784295
[TBL] [Abstract][Full Text] [Related]
20. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Dikeos D; Badr MG; Yang F; Pesek MB; Fábián Z; Tapia-Paniagua G; Hudiţă C; Okasha T; D'yachkova Y; Harrison G; Treuer T
World J Biol Psychiatry; 2010 Jun; 11(4):667-76. PubMed ID: 20334575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
